Evidence map›Paper›PMID 32252128›Full record

ArticleClinical and experimental emergency medicine2020

Damage control resuscitation.

Evan Leibner, Mark Andreae, Samuel M Galvagno, Thomas Scalea

Abstract read
In one paragraph

Article in Clinical and experimental emergency medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Bleeding resuscitation in the ambulance service, an observational study of standard care in Sweden.Scandinavian journal of trauma, resuscitation and emergency medicine · 2025
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Frontiers in bioengineering and biotechnology · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. ENGINEERED INTRAVENOUS THERAPIES FOR TRAUMA.Current opinion in biomedical engineering · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Evan LeibnerDepartment of Emergency Medicine, Institute of Critical Care Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Mark AndreaeDepartment of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Samuel M GalvagnoProgram in Trauma, Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Thomas ScaleaProgram in Trauma, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The United States Navy originally utilized the concept of damage control to describe the process of prioritizing the critical repairs needed to return a ship safely to shore during a maritime emergency. To pursue a completed repair would detract from the goal of saving the ship. This concept of damage control management in crisis is well suited to the care of the critically ill trauma patient, and has evolved into the standard of care. Damage control resuscitation is not one technique, but, rather, a group of strategies which address the lethal triad of coagulopathy, acidosis, and hypothermia. In this article, we describe this approach to trauma resuscitation and the supporting evidence base.

Indexed as

Advanced Trauma Life Support CareBlood Component TransfusionBlood TransfusionInfusions, IntravenousPlatelet TransfusionResuscitationWounds and injuries

Identifiers

PMID32252128
PMCPMC7141982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.